Neurological adverse events (NAEs) have been reported during immune checkpoint inhibitor (ICI) therapy, but their reporting spectrum and onset patterns across drugs and pharmacovigilance databases remain incompletely characterized.
We conducted a pharmacovigilance study of seven ICIs using the FDA Adverse Ev...
Hui-Ling Luo, Xian-Long Xie, Shi-Ran Qin et al.· Frontiers in Pharmacology· 0 citations
The molecular determinants underlying neutrophil functional heterogeneity are summarized, the dual role of neutrophils in host defense and tissue injury in SALI is discussed, and emerging evidence that natural products can alleviate SALI by modulating neutrophil recruitment, oxidative stress, inflammatory signaling, an...
Hui-Ling Luo, Jin-Yuan Lin, Hong-Lei Shen et al.· Frontiers in Pharmacology· 0 citations
Findings delineate a crucial TDP-43/SLC7A7/Ferroptosis axis in arsenic-induced liver injury, highlighting a post-transcriptional regulatory function of TDP-43 in mediating environmental metabolic toxicity.
Hui-Ling Luo, Wen-Juan Tan, Qi Wang et al.· Chemico-Biological Interacti...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.